AZD5363 Capivasertib AKT Inhibitors
| Product name:AZD5363 Capivasertib | Purity:98% min |
| CAS NO:1143532-39-1 | Solubility:DMSO : ≥ 21.5 mg/mL (50.13 mM) |
| Molecular Formula:C21H25ClN6O2 | Package:Package according to customer requirements |
| Molecular Weight:428.915 | Storage:Store at -20℃ |
AZD5363, also known as Capivasertib, is an orally available inhibitor of the serine/threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AKT inhibitor AZD5363 binds to and inhibits all AKT isoforms. Inhibition of AKT prevents the phosphorylation of AKT substrates that mediate cellular processes, such as cell division, apoptosis, and glucose and fatty acid metabolism. A wide range of solid and hematological malignancies show dysregulated PI3K/AKT/mTOR signaling due to mutations in multiple signaling components.
Related Products:
MK-2206 2HCl; Ipatasertib; Triciribine; PHT-427; Perifosine; CCT128930; AT7867; AT13148; ONC-201; Akti-1/2; SC66; Miltefosine; GSK690693
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.